symbol,asOfDate,periodType,currencyCode,AmortizationCashFlow,BeginningCashPosition,CapitalExpenditure,ChangeInCashSupplementalAsReported,ChangeInInventory,ChangeInOtherCurrentLiabilities,ChangeInPayable,ChangeInWorkingCapital,ChangesInCash,CommonStockDividendPaid,DeferredTax,Depreciation,DepreciationAndAmortization,EffectOfExchangeRateChanges,EndCashPosition,FinancingCashFlow,FreeCashFlow,GainLossOnInvestmentSecurities,GainLossOnSaleOfPPE,InvestingCashFlow,IssuanceOfDebt,LongTermDebtIssuance,LongTermDebtPayments,NetCommonStockIssuance,NetIncome,NetIncomeFromContinuingOperations,NetIntangiblesPurchaseAndSale,NetIssuancePaymentsOfDebt,NetLongTermDebtIssuance,NetOtherFinancingCharges,NetPPEPurchaseAndSale,OperatingCashFlow,OtherNonCashItems,PensionAndEmployeeBenefitExpense,ProvisionandWriteOffofAssets,PurchaseOfIntangibles,PurchaseOfPPE,RepaymentOfDebt,SaleOfPPE
FDA.MI,2019-09-30,TTM,EUR,,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,14000.0,,,,,
FDA.MI,2023-12-31,TTM,EUR,367000.0,4855000.0,-475000.0,-1957000.0,-552000.0,-739000.0,-1288000.0,-2579000.0,-1765000.0,,135000.0,915000.0,1282000.0,-192000.0,2898000.0,3429000.0,-5312000.0,-816000.0,-13000.0,-357000.0,4163000.0,4163000.0,-861000.0,9000.0,-1307000.0,-1473000.0,-303000.0,3302000.0,3302000.0,118000.0,-54000.0,-4837000.0,-25000.0,-659000.0,-689000.0,-303000.0,-172000.0,-861000.0,118000.0
